American Oncology Network, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
American Oncology Network, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2020 to Q2 2024.
  • American Oncology Network, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $3.29M.
  • American Oncology Network, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$11.5M, a 166% decline year-over-year.
  • American Oncology Network, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $2.59M.
  • American Oncology Network, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$105K, a 100% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.29M +$5M Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$7.8M -$7.98M -4447% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$5.22M +$978K +15.8% Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$1.79M -$5.2M -153% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$1.71M -$3.57M -192% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $179K -$3.34M -94.9% Mar 31, 2023 10-Q 2023-08-10
Q4 2022 -$6.2M +$2.87M +31.6% Dec 31, 2022 8-K 2023-11-27
Q3 2022 $3.41M +$151K +4.64% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.86M -$4.25M -69.6% Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $3.52M +$3.93M Mar 31, 2022 10-Q 2023-08-10
Q4 2021 -$9.07M -$9.07M Dec 31, 2021 8-K 2023-11-27
Q3 2021 $3.25M Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $6.12M Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$410K Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$834* Dec 31, 2020 10-K 2022-04-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.